Podcast

Jacob Sands, MD, on Lung Cancer Stigma

11/01/2019

 

In this podcast, Jacob Sands, MD, discusses lung cancer stigma, how it affects patient outcomes, and how providers can overcome the stigma.

Jacob Sands, MD, is a thoracic medical oncologist at the Dana-Farber Cancer Institute and instructor of medicine at Harvard Medical School in Boston, Massachusetts. He is also a spokesperson for the American Lung Association.

Additional Resources:


Published in partnership with American Lung Association

Related Content

Statins
Statins
James Matera, DO, on Whether Statins Are Safe in Comorbid Lipid Disorders and CKD
07/08/2021
James Matera, DO, discusses how lipid disorders impact the management of chronic kidney disease (CKD), and whether statins are safe for use in patients with comorbid lipid disorders and CKD.
07/08/2021
Kidney Failure
Kidney Failure
James Matera, MD, on Treating Hep C in ESRD, Renal Transplant Candidates
11/21/2018
James Matera, DO, details advances in the treatment of hepatitis C virus in patients with end-stage renal disease. He also explains why it may be beneficial to defer hepatitis C treatment until after renal...
11/21/2018
Multiple Sclerosis
Multiple Sclerosis
Pavan Bhargava, MD, on Metabolomic Profiling in MS Patients
04/23/2019
Pavan Bhargava, MD, discusses his latest research on metabolomic profiling in patients with multiple sclerosis, a topic in which he spoke about at ACTRIMS 2019 as well.
04/23/2019
Cardiology
Cardiology
Daniel Einhorn, MD, on HbA1c Guidelines Are Not Law
06/15/2018
Daniel Einhorn, MD, from Scripps Whittier Diabetes Institute talks about the "debate of 2018": ACP's new guidance on controlling HbA1c levels in adults with diabetes.
06/15/2018
Hypertension
Hypertension
TS Dharmarajan, MD, on Treating Hypertension in the Elderly Population
09/21/2018
TS Dharmarajan, MD, from the Wakefield Campus of Montefiore talks about treating hypertension in the elderly population as outlined by 3 different guidelines.
09/21/2018